2199.0000 -3.20 (-0.15%)
NSE Jun 19, 2026 15:31 PM
Volume: 287.6K
 

logo
Gland Pharma Ltd.
15 Feb 2024
2199.00
-0.15%
Axis Direct
China remains a key geographic focus area for the company. Gland has received and launched one product this year. Recommendation: HOLD
Number of FII/FPI investors decreased from 236 to 230 in Mar 2026 qtr
More from Gland Pharma Ltd.
Recommended